Equity Analysis
Why Did Baudax (BXRX) Stock Go 54% Higher In Pre-Market Session Today?
Following the pharmaceutical company’s announcement that a clinical study had begun, shares of Baudax Bio Inc. (NASDAQ: BXRX) were surging 54.05% to trade at $6.27 at the time of our last check. Which study has BXRX launched? Clinical research investigating the tolerability, safety aspect, and
